Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Grant or award Director acquired 19,290 shares (grant or award)
  2. 4 Grant or award Director acquired 38,580 shares (grant or award)
  3. 4 Grant or award Director acquired 38,580 shares (grant or award)
  4. 4 Open-market buy CEO & President bought 83,334 shares at $0.12 ($10,000)
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. 8-K Event Other events
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Bylaws or fiscal year change
  9. 4/A Grant or award Director acquired 27,412 shares (grant or award)
  10. 4/A Grant or award Director acquired 43,330 shares (grant or award)
  11. 4/A Grant or award Director acquired 25,797 shares (grant or award)
  12. 4 Grant or award Director acquired 43,330 shares (grant or award)
  13. 4 Grant or award Director acquired 43,330 shares (grant or award)
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. 8-K Event Other events
  17. 8-K Event Other events
  18. S-1/A Offering Registration Statement
  19. 8-K Event Other events
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 7 of 82 · 1,637 filings